Association of Tartrate-Resistant Acid Phosphatase-Expressed Macrophages and Metastatic Breast Cancer Progression.

Medicine (Baltimore) 2015 Dec;94(48):e2165

From the Division of Hematology/Oncology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC (Y-GC, R-HY, S-HL, M-SD); Special Hematology Laboratory, Veterans Administrative Medical Center, Louisville, KY (AJ); Division of Hematology/Oncology, Shuang-Ho Hospital, Taipei Medical University (T-YC); Division of Pathology, Tri-Service General Hospital, National Defense Medical Center (H-WG); and Division of Breast Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC (J-CY, G-SL).

Infiltrating neutrophils, lymphocytes, macrophages, and cytokines constitute a state of chronic inflammation within the tumor microenvironment. Tartrate-resistant acid phosphatase 5a (TRACP5a) protein, a novel product of activated macrophage, is postulated to be a biomarker for systemic inflammatory burden in states of chronic inflammation. We aimed to investigate the clinical significance of TRACP5a expression in tumor-infiltrating macrophages and serum TRACP5a in patients with metastatic breast cancer (BC). We retrospectively analyzed the clinical data from 34 BC patients with confirmed skeletal/visceral metastasis upon or during first-line palliative treatment. Patients were stratified into 3 groups based on the therapeutic responses and follow-up disease course. The association of TRACP5a protein with other inflammatory and cancer biomarkers was assessed among the clinically distinct group of patients. Higher TRACP5a protein was significantly correlated with earlier disease progression and survival (P = 0.0045) in comparison to other inflammatory markers, CRP or IL-6. Patients with higher serum TRACP5a level and shorter survival and treatment refractoriness also had more TRACP+ tumor-infiltrating macrophages. Our data support a hypothesis that serum TRACP5a protein can potentially be a predictive and prognostic marker to evaluate disease progression and therapeutic response in BC patients with bone/visceral metastasis. The associations between overall survival and TRACP expression by macrophages require further prospective investigation.

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000002165DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674201PMC
December 2015
12 Reads

Publication Analysis

Top Keywords

tracp5a protein
16
serum tracp5a
12
chronic inflammation
8
breast cancer
8
disease progression
8
patients higher
8
tumor-infiltrating macrophages
8
tartrate-resistant acid
8
metastatic breast
8
tracp5a
7
patients
6
macrophages
5
association tracp5a
4
protein inflammatory
4
inflammatory cancer
4
course association
4
disease course
4
follow-up disease
4
cancer biomarkers
4
responses follow-up
4

Similar Publications